OOO

ONCOSIL MEDICAL LTD

No trades
See on Supercharts
Market capitalization
‪20.73 M‬AUD
−0.007AUD
‪−11.34 M‬AUD
‪367.68 K‬AUD
‪2.81 B‬
Beta (1Y)
0.04

About ONCOSIL MEDICAL LTD

CEO
Nigel Lange
Headquarters
Macquarie Park
Founded
2005
ISIN
AU000000OSL3
FIGI
BBG000HM69P9
OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. It engages in the development of novel and safer radiation therapy treatments. The company was founded by David McAuliffe on April 14, 2005 and is headquartered in North Sydney, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OSL is 0.006 AUD — it has decreased by 14.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ONCOSIL MEDICAL LTD stocks are traded under the ticker OSL.
ONCOSIL MEDICAL LTD is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
OSL stock is 16.67% volatile and has beta coefficient of 0.04. Check out the list of the most volatile stocks — is ONCOSIL MEDICAL LTD there?
OSL earnings for the last quarter are 0.00 AUD per share, whereas the estimation was 0.00 AUD resulting in a −26.55% surprise. The estimated earnings for the next quarter are 0.00 AUD per share. See more details about ONCOSIL MEDICAL LTD earnings.
ONCOSIL MEDICAL LTD revenue for the last quarter amounts to ‪100.00 K‬ AUD despite the estimated figure of 0 AUD. In the next quarter revenue is expected to reach ‪600.00 K‬ AUD.
Yes, you can track ONCOSIL MEDICAL LTD financials in yearly and quarterly reports right on TradingView.
OSL stock hasn't changed in a week, the month change is a 9.25% fall, over the last year ONCOSIL MEDICAL LTD has showed a 36.47% decrease.
OSL net income for the last quarter is ‪−6.02 M‬ AUD, while the quarter before that showed ‪−5.69 M‬ AUD of net income which accounts for −5.73% change. Track more ONCOSIL MEDICAL LTD financial stats to get the full picture.
No, OSL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OSL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONCOSIL MEDICAL LTD stock right from TradingView charts — choose your broker and connect to your account.
OSL reached its all-time high on Jan 27, 2016 with the price of 0.204 AUD, and its all-time low was 0.005 AUD and was reached on Mar 27, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ONCOSIL MEDICAL LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ONCOSIL MEDICAL LTD stock shows the sell signal. See more of ONCOSIL MEDICAL LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ONCOSIL MEDICAL LTD EBITDA is ‪−12.66 M‬ AUD, and current EBITDA margin is ‪−3.37 K‬%. See more stats in ONCOSIL MEDICAL LTD financial statements.